How to treat the spread and metastasis of nasopharyngeal carcinoma

How to treat nasopharyngeal carcinoma metastasis?

1. Nasopharyngeal carcinoma refers to a malignant tumor that occurs on the top and side walls of the nasopharyngeal cavity. It is one of the most common malignant tumors in my country, and its incidence rate ranks first among malignant tumors of the ear, nose and throat. Common clinical symptoms include nasal congestion, blood in mucus, stuffy ears, hearing loss, diplopia and headache. Most nasopharyngeal carcinomas are moderately sensitive to radiotherapy, and radiotherapy is the first choice for nasopharyngeal carcinoma. However, for highly differentiated cancers, advanced disease course and recurrence after radiotherapy, surgical resection and chemotherapy are also indispensable means.

2. CLS biological multi-cell therapy technology is to inject highly active immune activation and effector cells into the patient's body, increase the number of immune cells in the body that recognize and directly kill tumors, stimulate the body's immune ability, and produce anti-tumor immune responses. This technology is considered to be the most advantageous and promising treatment method in the current comprehensive tumor treatment model due to its safety, high efficiency, and no toxic side effects.

3. The drawbacks of surgery, radiotherapy, and chemotherapy, such as incomplete treatment, easy metastasis, and strong toxic side effects, have troubled tumor experts. CLS biological multi-cell therapy can not only overcome these drawbacks, but also nearly double the five-year survival rate. It is recognized by the international medical community as the fourth largest tumor therapy. Because it is a systemic treatment for tumors, it has no obvious side effects on the human body and no obvious pain during treatment.